Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib

NCT06717100 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interactions

Interventions

DRUG: Nintedanib 150 MG [Ofev]

Sponsor

PureTech

Collaborators

[object Object]